Michael Aigner
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 33
- CAR-T cell therapy research 27
- Immunology 27
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 6
- Co-authors
- Andréas Mackensen (38 shared papers)Simon Völkl (25 shared papers)Georg Andreas Schett (16 shared papers)Dimitrios Mougiakakos (11 shared papers)Sascha Kretschmann (8 shared papers)Soraya Kharboutli (5 shared papers)Gerhard Krönke (5 shared papers)Bernhard Manger (2 shared papers)
- Journals
- Blood (5 papers)Leukemia (3 papers)International Polymer Processing (3 papers)Frontiers in Immunology (3 papers)The Lancet (3 papers)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Michael Aigner
81 papers receiving 4.0k citations
Michael Aigner's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 2.0k
- Immunology 1.4k
- Rheumatology 393
- Genetics 168
- Pathology and Forensic Medicine 274
Countries citing papers authored by Michael Aigner
This map shows the geographic impact of Michael Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Aigner more than expected).
Fields of papers citing papers by Michael Aigner
This network shows the impact of papers produced by Michael Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Aigner. The network helps show where Michael Aigner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Aigner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus Hit paper breakdown → | 2022 | 752 |
| 2 | CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up Hit paper breakdown → | 2024 | 657 |
| 3 | CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus Hit paper breakdown → | 2021 | 433 |
| 4 | CD19-targeted CAR T cells in refractory antisynthetase syndrome Hit paper breakdown → | 2023 | 203 |
| 5 | Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells Hit paper breakdown → | 2023 | 167 |
| 6 | 2010 | 142 | |
| 7 | 2012 | 116 | |
| 8 | 2004 | 97 | |
| 9 | 2013 | 84 | |
| 10 | CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis Hit paper breakdown → | 2024 | 78 |
| 11 | 2023 | 74 | |
| 12 | 2014 | 73 | |
| 13 | 2010 | 71 | |
| 14 | CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series Hit paper breakdown → | 2024 | 70 |
| 15 | 2005 | 60 | |
| 16 | 2012 | 56 | |
| 17 | 2016 | 54 | |
| 18 | Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study Hit paper breakdown → | 2025 | 52 |
| 19 | 2017 | 51 | |
| 20 | 2013 | 48 |
About Michael Aigner
Michael Aigner is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology, having authored 83 papers that have together received 4.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (27 papers), Immune Cell Function and Interaction (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Metal Alloys Wear and Properties (6 papers), T-cell and B-cell Immunology (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Oncology (2.0k citations), Immunology (1.4k citations), Rheumatology (393 citations), Genetics (168 citations) and Pathology and Forensic Medicine (274 citations). Michael Aigner has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Andréas Mackensen, Simon Völkl, Georg Andreas Schett, Dimitrios Mougiakakos, Sascha Kretschmann, Soraya Kharboutli, Gerhard Krönke, Bernhard Manger, Sebastian Böltz and Fabian Müller. Their work appears in journals such as Blood, Leukemia, International Polymer Processing, Frontiers in Immunology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.